GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,778.50p
   
  • Change Today:
    -9.50p
  • 52 Week High: 1,789.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,060.14m
  • Volume: 12,770,936
  • Market Cap: £72,210m
  • RiskGrade: 129
  • Beta: 0.93

Latest ShareCast News

GSK posts better-than-expected Q3, upgrades guidance

By Josh White

Date: Wednesday 29 Oct 2025

(Sharecast News) - GSK raised its full-year guidance on Wednesday, after delivering stronger-than-expected third-quarter results, driven by robust growth in specialty medicines and steady contributions from its vaccines and general medicines divisions.

GSK lung cancer treatment gets EU orphan drug status

By Frank Prenesti

Date: Tuesday 28 Oct 2025

(Sharecast News) - GSK on Tuesday said its treatment for small-cell lung cancer (SCLC) had received orphan drug status from the European Medicines Agency.

GSK shares lift on £268m prostate cancer deal

By Frank Prenesti

Date: Monday 27 Oct 2025

(Sharecast News) - GSK shares lifted on Monday after the pharmaceutical giant signed a £268m deal with French biotech Syndivia for a potential treatment for prostate cancer.

GSK's Blenrep receives US FDA approval 24-Oct-2025 ShareCast
GSK advances low-carbon inhaler, halts latozinem... 22-Oct-2025 ShareCast
GSK reports positive trial data for oral cUTI tr... 21-Oct-2025 ShareCast
GSK shingles vaccine approved for expanded use i... 14-Oct-2025 ShareCast
London midday: UK stocks keep grinding towards y... 03-Oct-2025 ShareCast
Emma Walmsley to step down as chief executive of... 29-Sep-2025 ShareCast
Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast
GSK plans $30bn US investment as pharma faces ta... 17-Sep-2025 ShareCast
GSK gepotidacin edges closer to landmark approva... 11-Aug-2025 ShareCast
GSK and CureVac secure $740m payout in mRNA pate... 08-Aug-2025 ShareCast
London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on robust US data, ea... 30-Jul-2025 ShareCast
GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
GSK and Hengrui unveil development deal worth up... 28-Jul-2025 ShareCast
London close: FTSE finishes week just shy of 9,000 18-Jul-2025 ShareCast
FDA rejects overall benefit/risk profile of GSK'... 18-Jul-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,778.50p
Change Today -9.50p
% Change -0.53 %
52 Week High 1,789.50
52 Week Low 1,264.00
Volume 12,770,936
Shares Issued 4,060.14m
Market Cap £72,210m
Beta 0.93
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for 06-Nov-2025

Time Volume / Share Price
16:23 1 @ 1,778.00p
16:23 171 @ 1,778.00p
16:23 0 @ 1,778.00p
16:23 2 @ 1,778.00p
16:22 0 @ 1,778.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page